ArticleDiscover oncology2025

A signature constructed with circadian rhythm-related genes to predict the prognosis and therapy response for low-grade gliomas.

Yiqiang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.